Synopsis:
In 2025, several stocks backed by Mukul Agarwal have shown remarkable gains, with ASM Technologies taking the lead and boasting a fantastic 206% return so far this year, and many other companies.
These companies span various sectors like engineering services, pharmaceuticals, healthcare, and digital solutions, reflecting strong growth momentum and attracting plenty of investor interest. As per the latest corporate shareholdings filed, Mukul Agrawal publicly holds 65 stocks with a net worth of over Rs. 7,776 Crore.
1. ASM Technologies
ASM Technologies Limited is engaged in engineering, consulting, and product development services. They specialize in a range of solutions, including automation, digital engineering, IoT, cybersecurity, IT infrastructure, and VR/AR technologies.
Their expertise spans key sectors such as automotive, avionics, medical, semiconductor, and high-tech industries, where they assist clients with design, manufacturing, and digital transformation.
So far in 2025, the company’s stock has delivered a robust return of 206 percent. Its returns over the previous six months and one month currently stand at 230 percent and 20 percent, respectively. As of Q1FY26, Mukul Agrawal holds a 10.86 percent stake.
2. Zota Health Care
Zota Health Care Limited is engaged in the development, manufacturing, and marketing of pharmaceutical products both in India and internationally. Their diverse portfolio features generic medicines, wellness products, OTC items, ayurvedic remedies, and nutraceuticals.
The company focuses on treating chronic conditions like diabetes, heart issues, and thyroid disorders, and operates retail pharmacies under the DAVAINDIA brand while also exporting its products.
So far in 2025, the company’s stock has delivered a robust return of 80 percent. Its returns over the previous six months and one month currently stand at 74 percent and 18 percent respectively. As of Q1FY26, Mukul Agrawal holds an 8 percent stake.
3. Yatharth Hospital & Trauma Care Services
Yatharth Hospital & Trauma Care Services Ltd. runs super-speciality hospitals in Delhi and Madhya Pradesh, providing a comprehensive array of medical services in essential fields such as cardiology, neurology, orthopaedics, oncology, critical care, and transplant surgeries.
They also offer cutting-edge treatments like robotic surgery, IVF, and fertility care, as well as bone marrow transplants. Beyond healthcare, the hospital generates revenue through pharmacy sales and canteen operations.
So far in 2025, the company’s stock has delivered a return of 32 percent. Its returns over the previous six months and one month currently stand at 78 percent and 8 percent respectively. As of Q1FY26, Mukul Agrawal holds a 1 percent stake.
Also Read: Market Opening Bell: Sensex opens at 80,541; Nifty at 24,691 – Mahindra & Mahindra,Bharat Electronics in focus today
4. Strides Pharma Science
Strides Pharma Science Limited is involved in the development, manufacturing, and sale of pharmaceutical products across various regions, including Africa, Australia, North America, Europe, and Asia. They provide generic medicines in multiple forms, such as tablets, capsules, sachets, liquids, sprays, gels, and creams.
Additionally, they create branded generics for chronic therapies related to women’s health, CNS, cardiovascular issues, diabetes, dermatology, and probiotics, with well-known brands like Renerve, Unibrol, Combiart, Duotab, and Vitafer. They also produce medications for infectious diseases, including HIV, malaria, tuberculosis, and hepatitis.
So far in 2025, the company’s stock has delivered a robust return of 18 percent. Its returns over the previous six months and one month currently stand at 24 percent and (-9) percent respectively. As of Q1FY26, Mukul Agrawal holds a 1.16 percent stake.
5. InfoBeans Technologies
InfoBeans Technologies Limited specializes in designing, building, and managing digital applications both in India and around the globe, including the UAE, Germany, and the US. Their services encompass AI (both narrow and generative), enterprise applications, cloud solutions, application modernization, and managed services.
They also provide packaged solutions like QA automation, platform-based offerings such as ServiceNow, Salesforce, and DevOps, along with industry-specific tools like Stanza and DataMind. Their clientele includes sectors like banking, financial services, insurance, manufacturing, technology, and standards organizations.
So far in 2025, the company’s stock has delivered a robust return of 18 percent. Its returns over the previous six months and one month currently stand at 65 percent and (-20) percent respectively. As of Q1FY26, Mukul Agrawal holds a 4.38 percent stake.
Written by Satyajeet Mukherjee
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
